Telemetry Investments »

Rapt Therapeutics shares owned by Telemetry Investments

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Telemetry Investments from 13F filings

Historical chart of Telemetry Investments investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Telemetry Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Telemetry Investments

Quarter filed Position value Share count Share price at filing
2022-12-31 $238k 12k 19.83

More positions owned by Telemetry Investments

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Silver Spike Acquisitn Corp Class A Ord Shs
Activision Blizzard
Atyr Pharma Com New (LIFE)
Trajectory Alpha Acquisition Com Cl A (TCOA)
Shuaa Partners Acquistn Corp Unit 02/24/2027
Invesco Exch Traded Fd Tr Ii Sr Ln Etf Put Option (BKLN)
Home Plate Acquisition Corp Cl A Com
Store Capital Corp reit
Amryt Pharma Sponsored Ads
Battery Future Acquisition C Cl A Ord Shs (BFAC)
Moneygram Intl Com New
Paratek Pharmaceuticals
Viewray (VRAYQ)

View all positions for Telemetry Investments

Top funds holding Rapt Therapeutics

FMR
Column Group
Vanguard Group
BlackRock
T. Rowe Price Associates
Morgan Stanley
Kingdon Capital Management
Perceptive Advisors
Geode Capital Management
Redmile Group
Euclidean Capital
Dimensional Fund Advisors
Alphabet
Cormorant Asset Management
Ikarian Capital

View all funds holding Rapt Therapeutics